Sable Bio raises €3.2M Seed round
11 February 2026· London, United Kingdom· health, drug_discovery, ai, biotech, b2b, pure_software
The funding will be used to expand the London-based team, accelerate product development, and integrate real-world evidence into the drug safety platform.
Investors
LeadMMC Ventures
Also participating
SeedcampEpisode 1 Ventures
About Sable Bio
Stage
Seed
Headquarters
London, United Kingdom
Founded
2023
Team Size
6–20
Sectors
healthdrug_discoveryaibiotechb2bpure_software